Unknown PHASE1/PHASE2 INTERVENTIONAL NCT00953485

Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)

Clinical Trial of Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome - Phase Ⅰ/Ⅱ

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions Mesenchymal Stem Cells Sjogren's Syndrome

Interventions Allogeneic Mesenchymal Stem Cells (AlloMSC)

Updated 5 times since 2017 Last updated: Aug 19, 2009 Started: Jun 30, 2009 Primary completion: Dec 31, 2010 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Mesenchymal Stem Cells and Sjogren's Syndrome, this trial is ongoing. The trial is conducted by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Data source: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China